4//SEC Filing
Levisetti Matteo 4
Accession 0000950170-24-018724
CIK 0001645460other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:00 PM ET
Size
5.5 KB
Accession
0000950170-24-018724
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-20+25,000→ 25,000 totalExercise: $3.36Exp: 2033-01-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001962444
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:00 PM ET
- Size
- 5.5 KB